Iron is essential for oxygen transport and energy metabolism but excess iron accumulation within body organs can be detrimental. This is particularly true for the nervous system, where iron storage is tightly regulated and non-uniformly distributed. Excess iron, either from excess accumulation or from defects in iron metabolism, can lead to oxidative stress and protein aggregation, which may eventually lead to the formation of intracellular inclusion bodies often associated with neurodegenerative diseases 1 . The syndromes of neurodegeneration with brain iron accumulation (NBIA) highlight the way in which clinically progressive neurologic dysfunction can be associated with distinct patterns of excessive iron deposition within the brain.
Neurodegeneration with brain iron accumulation disorders encompass a clinically heterogeneous spectrum of inherited childhood and adult-onset progressive neurodegenerative disease. Considerable work has been done since the original description of the Hallervorden-Spatz Syndrome (HSS) to differentiate and define specific NBIA disorders based on clinical, radiographic, pathophysiologic and genetic features 2 . Currently, NBIA syndromes include the autosomal recessive neuroaxonal dystrophies pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN), as well as Kufor-Rakeb Disease, FA2H-Associated Neurodegeneration (FAHN) and WoodhouseSakati Syndrome. It also includes the autosomal recessive disorder aceruloplasminemia and the autosomal dominant disorder neuroferritinopathy, in addition to the static encephalopathy of childhood with neurodegeneration in adulthood (SNEDA) syndrome and other genetically yet undetermined conditions 3, 4 .
The unifying characteristic of the NBIA disorders is the excessive symmetric deposition of iron in key gray matter nuclei, which can be identified using specific magnetic resonance imaging (MRI) techniques. Areas rich in iron appear hypointense on T2-weighted MRI sequences, isointense on T1-weighted sequences and can be accentuated with T2* (gradient echo) sequences 5 .
The exact pathophysiology and role of iron accumulation in these disorders is yet to be completely understood. Loss of PLA2G6 protein function in PLAN can result in axonal pathology and subsequent iron accumulation 6 . Disruption of the PANK2 gene product in PKAN can lead to mitochondrial dysfunction, apoptosis and build up of metabolites such as cysteine, which is a potent iron chelator. The subsequent accumulation of iron results in further cellular injury through oxidative stress 6 . Ultimately, many NBIA disorders may act on related metabolic pathways. For example, it has been proposed that these disorders may affect ceramide, which has a central role in sphingolipid metabolism. Ceramide has been implicated in mitochondrial processes of apoptosis 7 and has been proposed to be associated with the formation of Lewy body inclusions 8 , relating NBIA disorders to other neurodegenerative processes.
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